旅遊疫苗市場規模、佔有率、成長分析（按成分、按接種途徑、按疾病、按旅行類型、按年齡層、按地區）－2025-2032 年行業預測

2023 年全球旅遊疫苗市場規模價值為 51.9 億美元，預計將從 2024 年的 57.4 億美元成長到 2032 年的 119.3 億美元，預測期內（2025-2032 年）的複合年成長率為 9.6%。

由於健康意識的增強、國際旅行的增加以及政府積極的疫苗接種舉措，全球旅行疫苗市場正在經歷顯著成長。由於消費者優先保護自己的健康感染疾病，對預防措施的需求很大，並推動了疫苗開發和交付的創新。疫情後的旅行趨勢增加了接種疫苗的緊迫性，特別是針對黃熱病和甲型肝炎等疾病的疫苗接種，許多國家現在要求入境時提供疫苗接種證明。由於醫療基礎設施不發達，新興經濟體對疫苗的需求激增。然而，挑戰依然存在，例如疫苗儲存的低溫運輸物流和監管複雜性。儘管存在這些障礙，政府、非政府組織和私營部門之間的合作對於發展市場和克服准入障礙至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 細分機會分析

市場動態與展望

• 市場概覽
• 供需趨勢分析
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 管道分析
• 專利分析
• 定價分析
• FDA分析
• 案例研究分析
• 技術評估

旅行疫苗市場規模（按成分和複合年成長率） (2025-2032)

• 市場概覽
• 單藥疫苗
• 聯合疫苗

旅行疫苗市場規模（按接種途徑和複合年成長率） (2025-2032)

• 市場概覽
• 注射疫苗
• 鼻內疫苗
• 口服疫苗

旅行疫苗市場規模（依疾病區分）及複合年成長率（2025-2032）

• 市場概覽
• 甲型肝炎
• 黃熱病
• 傷寒
• B型肝炎
• 麻疹和腮腺炎
• 狂犬病
• 流感
• 其他

旅行疫苗市場規模（按旅行類型和複合年成長率） (2025-2032)

• 市場概覽
• 國內的
• 國外

旅行疫苗市場規模（依年齡層及複合年成長率） (2025-2032)

• 市場概覽
• 嬰兒
• 成人
• 老年人

旅行疫苗市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck & Co., Inc.
• AstraZeneca
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Takeda Pharmaceutical
• VBI Vaccine Inc.
• Bavarian Nordic
• CSL
• Valneva SE
• Johnson & Johnson Services Inc.（Crucell）
• Dynavax Technologies
• Novartis AG
• Bharat Biotech
• Emergent BioSolutions
• Hualan Biological Engineering Inc.
• Serum Institute of India Pvt. Ltd.
• Zydus Group

結論和建議

Global Travel Vaccines market size was valued at USD 5.19 Billion in 2023 and is poised to grow from USD 5.74 Billion in 2024 to USD 11.93 Billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The global travel vaccine market is experiencing remarkable growth driven by heightened health awareness, increased international travel, and proactive government vaccination initiatives. As consumers prioritize health protection against infectious diseases, there's a notable demand for preventative measures, propelling innovation in vaccine development and delivery. Post-pandemic travel trends have enhanced the urgency for vaccinations, particularly for diseases like yellow fever and hepatitis A, with many countries imposing vaccination proof for entry. Emerging economies are seeing a surge in vaccine demand due to less developed health infrastructures. Yet, challenges such as cold-chain logistics for vaccine storage and regulatory complexities persist. Despite these hurdles, collaboration among governments, NGOs, and the private sector is crucial for market advancement and overcoming access barriers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

The global Travel Vaccines Market is segmented by Composition, Administration Route, Diseases, Travel Type, Age Group and region. Based on Composition, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Administration Route, the market is segmented into Injectable Vaccines, Intranasal Vaccines and Oral Vaccines. Based on Diseases, the market is segmented into Hepatitis A, Yellow Fever, Typhoid, Hepatitis B, Measles & Mumps, Rabies, Influenza and Others. Based on Travel Type, the market is segmented into Domestic and Outbound. Based on Age Group, the market is segmented into Infants & Children, Adults and Elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

The global travel vaccines market is significantly driven by the resurgence of international tourism, which has seen a remarkable recovery post-pandemic. In 2023, the UNWTO reported that international tourist arrivals climbed to 1.29 billion, marking a notable rebound. Countries such as Saudi Arabia and Australia have implemented strict vaccination requirements for travelers coming from endemic areas, specifically for diseases like yellow fever. This regulatory push has heightened the necessity for travel vaccines, resulting in impressive revenue growth for pharmaceutical companies. For instance, Sanofi highlighted a 10.4% increase in travel vaccine revenues in their 2023 annual report, illustrating the growing demand fueled by health regulations.

Restraints in the Global Travel Vaccines Market

The Global Travel Vaccines market faces significant constraints primarily due to the high out-of-pocket costs associated with these vaccines, which can deter individuals from seeking them. As reported by the CDC in 2023, common vaccines such as yellow fever and typhoid can range from $150 to $350 per dose, and most insurance plans do not cover these expenses. Companies, including Emergent BioSolutions, highlighted in their 2023 Annual Report that the affordability of vaccines is a major hurdle for broader market acceptance, especially among cost-sensitive travelers in developing nations. This financial barrier limits access and reduces the overall uptake of essential travel immunizations.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is experiencing a notable upward trend, particularly driven by heightened demand for COVID-19 booster doses as international travel regulations become increasingly stringent. With countries such as the U.S. and those in the EU enforcing updated vaccination requirements for travelers, pharmaceutical giants like Pfizer and Moderna are scaling production to meet this surge. Analysts project that sales of COVID-19 booster shots are set to grow by 15-20% in 2024, propelled by guidelines from authorities like the CDC, which emphasize the importance of booster vaccinations for individuals traveling to high-risk regions. This trend highlights the evolving landscape of travel health and safety.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Supply & Demand Trend Analysis
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Pipeline Analysis
• Patent Analysis
• Pricing Analysis
• FDA Analysis
• Case Study Analysis
• Technology Assessment

Global Travel Vaccines Market Size by Composition & CAGR (2025-2032)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Administration Route & CAGR (2025-2032)

• Market Overview
• Injectable Vaccines
• Intranasal Vaccines
• Oral Vaccines

Global Travel Vaccines Market Size by Diseases & CAGR (2025-2032)

• Market Overview
• Hepatitis A
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles & Mumps
• Rabies
• Influenza
• Others

Global Travel Vaccines Market Size by Travel Type & CAGR (2025-2032)

• Market Overview
• Domestic
• Outbound

Global Travel Vaccines Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Infants & Children
• Adults
• Elderly

Global Travel Vaccines Market Size & CAGR (2025-2032)

• North America (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • US
  • Canada
• Europe (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VBI Vaccine Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc. (Crucell)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations